{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T17:55:14Z","timestamp":1785866114607,"version":"3.56.0"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.trim.2021.101518","type":"journal-article","created":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T02:00:55Z","timestamp":1639620055000},"page":"101518","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Clinical and diagnostic potential of regulatory T cell markers: From bench to bedside"],"prefix":"10.1016","volume":"70","author":[{"given":"Mohammad Hossein","family":"Haddadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babak","family":"Negahdari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trim.2021.101518_bb0005","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.autrev.2017.03.011","article-title":"Regulatory immune cells and functions in autoimmunity and transplantation immunology","volume":"16","author":"Papp","year":"2017","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.trim.2021.101518_bb0010","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/TP.0000000000000243","article-title":"Regulatory T-cell therapy in the induction of transplant tolerance: the issue of subpopulations","volume":"98","author":"Edozie","year":"2014","journal-title":"Transplantation."},{"key":"10.1016\/j.trim.2021.101518_bb0015","first-page":"723","article-title":"Cell interactions in the induction of tolerance: the role of thymic lymphocytes","volume":"18","author":"Gershon","year":"1970","journal-title":"Immunology."},{"key":"10.1016\/j.trim.2021.101518_bb0020","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fimmu.2019.00043","article-title":"Past, present, and future of regulatory T cell therapy in transplantation and autoimmunity","volume":"10","author":"Romano","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trim.2021.101518_bb0025","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/s41573-019-0041-4","article-title":"Next-generation regulatory T cell therapy","volume":"18","author":"Ferreira","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.trim.2021.101518_bb0030","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad4134","article-title":"Type 1 diabetes immunotherapy using polyclonal regulatory T cells","volume":"7","author":"Bluestone","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.trim.2021.101518_bb0035","first-page":"S84","article-title":"Therapy of type 1 diabetes with CD4(+) CD25(high)CD127-regulatory T cells prolongssurvival of pancreatic islets-results of one year follow-up","volume":"17","author":"Marek-Trzonkowska","year":"2015","journal-title":"Diabetes Technol. Ther."},{"key":"10.1016\/j.trim.2021.101518_bb0040","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/art.40737","article-title":"Adoptive Treg cell therapy in a patient with systemic lupus erythematosus","volume":"71","author":"Dall\u2019Era","year":"2019","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.trim.2021.101518_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2019.100645","article-title":"Autoimmunity as a target for chimeric immune receptor therapy: a new vision to therapeutic potential","volume":"41","author":"Haddadi","year":"2020","journal-title":"Blood Rev."},{"key":"10.1016\/j.trim.2021.101518_bb0050","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/nri3108","article-title":"The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses","volume":"11","author":"Walker","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.trim.2021.101518_bb0055","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s10875-019-00684-7","article-title":"Regulatory T cells: the many faces of Foxp3","volume":"39","author":"Georgiev","year":"2019","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.trim.2021.101518_bb0060","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/jmv.25312","article-title":"Detection of regulatory T cell phenotypic markers and cytokines in patients with human papillomavirus infection","volume":"91","author":"Bonin","year":"2019","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.trim.2021.101518_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105981","article-title":"MSCs exosomal miR-1470 promotes the differentiation of CD4+CD25+FOXP3+ Tregs in asthmatic patients by inducing the expression of P27KIP1","volume":"77","author":"Zhuansun","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.trim.2021.101518_bb0070","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/TP.0000000000002495","article-title":"Mtor inhibitor everolimus in regulatory t cell expansion for clinical application in transplantation","volume":"103","author":"Gedaly","year":"2019","journal-title":"Transplantation."},{"key":"10.1016\/j.trim.2021.101518_bb0075","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1007\/s10753-012-9496-8","article-title":"CD4+CD25+CD127low\/\u2212 T cells: a more specific treg population in human peripheral blood","volume":"35","author":"Yu","year":"2012","journal-title":"Inflammation."},{"key":"10.1016\/j.trim.2021.101518_bb0080","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1084\/jem.20060772","article-title":"CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells","volume":"203","author":"Liu","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.trim.2021.101518_bb0085","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1002\/ijc.32024","article-title":"Regulatory T cells expressing abundant CTLA-4 on the cell surface with a proliferative gene profile are key features of human head and neck cancer","volume":"144","author":"Matoba","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.trim.2021.101518_bb0090","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/TP.0000000000001278","article-title":"CD45RA distinguishes CD4+CD25+CD127\u2212\/low TSDR demethylated regulatory T cell subpopulations with differential stability and susceptibility to tacrolimus-mediated inhibition of suppression","volume":"101","author":"Hornero","year":"2017","journal-title":"Transplantation."},{"key":"10.1016\/j.trim.2021.101518_bb0095","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.3389\/fimmu.2018.02540","article-title":"Molecular markers distinguishing T cell subtypes with TSDR strand-bias methylation","volume":"9","author":"Minskaia","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trim.2021.101518_bb0100","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jaut.2017.07.002","article-title":"Induction and maintenance of regulatory T cells by transcription factors and epigenetic modifications","volume":"83","author":"Iizuka-Koga","year":"2017","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.trim.2021.101518_bb0105","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1002\/eji.200425274","article-title":"Interleukin-2 is essential for CD4+CD25+ regulatory T cell function","volume":"34","author":"de la Rosa","year":"2004","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.trim.2021.101518_bb0110","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.jaci.2009.02.011","article-title":"IL-2- and CD25-dependent immunoregulatory mechanisms in the homeostasis of T-cell subsets","volume":"123","author":"L\u00e9tourneau","year":"2009","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.trim.2021.101518_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-08960-1","article-title":"Essential and non-overlapping IL-2R\u03b1-dependent processes for thymic development and peripheral homeostasis of regulatory T cells","volume":"10","author":"Toomer","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trim.2021.101518_bb0120","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/s41423-020-0476-x","article-title":"Differential DNA methylation in allergen-specific immunotherapy of asthma","volume":"17","author":"Wang","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.trim.2021.101518_bb0125","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1084\/jem.20131142","article-title":"CCR7 provides localized access to IL-2 and defines homeostatically distinct regulatory T cell subsets","volume":"211","author":"Smigiel","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.trim.2021.101518_bb0130","doi-asserted-by":"crossref","first-page":"5067","DOI":"10.1158\/1078-0432.CCR-10-1757","article-title":"Dendritic cell vaccination in combination with anti-CD25 monoclonal antibody treatment: a phase I\/II study in metastatic melanoma patients","volume":"16","author":"Jacobs","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.trim.2021.101518_bb0135","doi-asserted-by":"crossref","first-page":"10411","DOI":"10.2147\/CMAR.S265828","article-title":"Regulatory t cells in cancer immunotherapy: Basic research outcomes and clinical directions","volume":"12","author":"Zeng","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.trim.2021.101518_bb0140","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.3389\/fimmu.2019.01583","article-title":"Generation of Foxp3+CD25\u2212 regulatory T-cell precursors requires c-rel and I\u03baBNS","volume":"10","author":"Schuster","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trim.2021.101518_bb0145","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jaut.2017.07.009","article-title":"Cells with Treg-specific FOXP3 demethylation but low CD25 are prevalent in autoimmunity","volume":"84","author":"Ferreira","year":"2017","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.trim.2021.101518_bb0150","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.4049\/jimmunol.182.3.1689","article-title":"Phenotypic and functional analysis of CD4 + CD25 \u2212 Foxp3 + T cells in patients with systemic lupus erythematosus","volume":"182","author":"Bonelli","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.trim.2021.101518_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-25574-7","article-title":"A phase i clinical trial with ex vivo expanded recipient regulatory T cells in living donor kidney transplants","volume":"8","author":"Mathew","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.trim.2021.101518_bb0160","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/cei.13194","article-title":"From stability to dynamics: understanding molecular mechanisms of regulatory T cells through Foxp3 transcriptional dynamics","volume":"197","author":"Bending","year":"2019","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.trim.2021.101518_bb0165","doi-asserted-by":"crossref","first-page":"4061","DOI":"10.3389\/fimmu.2021.750542","article-title":"Regulatory T cells: regulation of identity and function","volume":"12","author":"Grover","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trim.2021.101518_bb0170","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/nyas.13011","article-title":"From IPEX syndrome to FOXP3 mutation: a lesson on immune dysregulation","volume":"1417","author":"Bacchetta","year":"2016","journal-title":"Ann. N. Y. Acad."},{"key":"10.1016\/j.trim.2021.101518_bb0175","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/s41590-020-0694-5","article-title":"Foxp3: a genetic foundation for regulatory T cell differentiation and function","volume":"21","author":"Ramsdell","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.trim.2021.101518_bb0180","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1093\/jimmunol\/198.3.993","article-title":"An essential role for Scurfin in CD4+CD25+T regulatory cells","volume":"198","author":"Khattri","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.trim.2021.101518_bb0185","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1093\/jimmunol\/198.3.986","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"198","author":"Fontenot","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.trim.2021.101518_bb0190","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.4161\/cc.6.12.4421","article-title":"FOXP3 actively represses transcription by recruiting the HAT\/HDAC complex","volume":"6","author":"Li","year":"2007","journal-title":"Cell Cycle"},{"key":"10.1016\/j.trim.2021.101518_bb0195","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nature05673","article-title":"Foxp3 controls regulatory T-cell function by interacting with AML1\/Runx1","volume":"446","author":"Ono","year":"2007","journal-title":"Nature."},{"key":"10.1016\/j.trim.2021.101518_bb0200","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/s41590-019-0442-x","article-title":"Functional reprogramming of regulatory T cells in the absence of Foxp3","volume":"20","author":"Charbonnier","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.trim.2021.101518_bb0205","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/intimm\/dxm014","article-title":"Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production","volume":"19","author":"Allan","year":"2007","journal-title":"Int. Immunol."},{"key":"10.1016\/j.trim.2021.101518_bb0210","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nri.2017.75","article-title":"The regulation of immune tolerance by FOXP3","volume":"17","author":"Lu","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.trim.2021.101518_bb0215","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1182\/blood-2006-06-027409","article-title":"Only the CD45RA+ subpopulation of CD4+CD25 high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion","volume":"108","author":"Hoffmann","year":"2006","journal-title":"Blood."},{"key":"10.1016\/j.trim.2021.101518_bb0220","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.4049\/jimmunol.0901065","article-title":"De novo generation and enhanced suppression of human CD4 + CD25 + regulatory T cells by retinoic acid","volume":"183","author":"Wang","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.trim.2021.101518_bb0225","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1111\/ajt.12899","article-title":"Demethylation of the TSDR is a marker of squamous cell carcinoma in transplant recipients","volume":"14","author":"Sherston","year":"2014","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2021.101518_bb0230","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3389\/fimmu.2020.00723","article-title":"Role of regulatory T cells in disturbed immune homeostasis in patients with chronic obstructive pulmonary disease","volume":"11","author":"Hou","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trim.2021.101518_bb0235","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jim.2006.10.008","article-title":"Human CD4+ regulatory T cells express lower levels of the IL-7 receptor alpha chain (CD127), allowing consistent identification and sorting of live cells","volume":"319","author":"Hartigan-O\u2019Connor","year":"2007","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.trim.2021.101518_bb0240","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.cmet.2016.01.010","article-title":"Regulatory T cell immunotherapy for type 1 diabetes: a step closer to success?","volume":"23","author":"Bayry","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.trim.2021.101518_bb0245","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1080\/08916934.2016.1199020","article-title":"Ex vivo expanded regulatory T cells CD4+CD25+FoxP3+CD127Low develop strong immunosuppressive activity in patients with remitting-relapsing multiple sclerosis","volume":"49","author":"Lifshitz","year":"2016","journal-title":"Autoimmunity."},{"key":"10.1016\/j.trim.2021.101518_bb0250","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1146\/annurev.immunol.24.021605.090727","article-title":"Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis","volume":"24","author":"Ma","year":"2006","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.trim.2021.101518_bb0255","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.molmed.2013.03.005","article-title":"CD39 and CD73 in immunity and inflammation","volume":"19","author":"Antonioli","year":"2013","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.trim.2021.101518_bb0260","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1002\/eji.201242909","article-title":"CD73 expression on extracellular vesicles derived from CD4+CD25+Foxp3+ T cells contributes to their regulatory function","volume":"43","author":"Smyth","year":"2013","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.trim.2021.101518_bb0265","first-page":"65","article-title":"Surface expression of gpA33 is dependent on culture density and cell-cycle phase and is regulated by intracellular traffic rather than gene transcription","volume":"23","author":"Frey","year":"2008","journal-title":"Cancer Biother. Radiopharm."},{"key":"10.1016\/j.trim.2021.101518_bb0270","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.4049\/jimmunol.1901250","article-title":"GPA33: a marker to identify stable human regulatory T cells","volume":"204","author":"Opstelten","year":"2020","journal-title":"J. Immunol."},{"key":"10.1016\/j.trim.2021.101518_bb0275","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1126\/science.1160062","article-title":"CTLA-4 control over Foxp3+ regulatory T cell function","volume":"322","author":"Wing","year":"2008","journal-title":"Science."},{"key":"10.1016\/j.trim.2021.101518_bb0280","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1126\/science.1202947","article-title":"Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4","volume":"332","author":"Qureshi","year":"2011","journal-title":"Science."},{"key":"10.1016\/j.trim.2021.101518_bb0285","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1093\/rheumatology\/40.6.662","article-title":"Association of CTLA-4 but not CD28 gene polymorphisms with systemic lupus erythematosus in the Japanese population","volume":"40","author":"Ahmed","year":"2001","journal-title":"Rheumatology."},{"key":"10.1016\/j.trim.2021.101518_bb0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13578-018-0229-z","article-title":"Anti-CTLA-4 antibodies in cancer immunotherapy: selective depletion of intratumoral regulatory T cells or checkpoint blockade?","volume":"8","author":"Tang","year":"2018","journal-title":"Cell Biosci."},{"key":"10.1016\/j.trim.2021.101518_bb0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11882-017-0740-z","article-title":"Checkpoint inhibitors: applications for autoimmunity","volume":"17","author":"Tocheva","year":"2017","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.trim.2021.101518_bb0300","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/art.24181","article-title":"CTLA-4 (CD152) controls homeostasis and suppressive capacity of regulatory T cells in mice","volume":"60","author":"Kolar","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.trim.2021.101518_bb0305","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.apsb.2019.09.006","article-title":"Epigenetic strategies synergize with PD-L1\/PD-1 targeted cancer immunotherapies to enhance antitumor responses","volume":"10","author":"Chen","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.trim.2021.101518_bb0310","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/07357907.2017.1324032","article-title":"Immunological characteristics of colitis associated with anti-CTLA-4 antibody therapy","volume":"35","author":"Bamias","year":"2017","journal-title":"Cancer Investig."},{"key":"10.1016\/j.trim.2021.101518_bb0315","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1002\/eji.200324632","article-title":"Suppressive properties of human CD4+CD25+ regulatory T cells are dependent on CTLA-4 expression","volume":"34","author":"Birebent","year":"2004","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.trim.2021.101518_bb0320","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1073\/pnas.0910341107","article-title":"Dual function of CTLA-4 in regulatory T cells and conventional T cells to prevent multiorgan autoimmunity","volume":"107","author":"Jain","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.trim.2021.101518_bb0325","doi-asserted-by":"crossref","first-page":"274","DOI":"10.4049\/jimmunol.182.1.274","article-title":"CTLA-4 controls regulatory T cell peripheral homeostasis and is required for suppression of pancreatic islet autoimmunity","volume":"182","author":"Schmidt","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.trim.2021.101518_bb0330","first-page":"2996","article-title":"University of California Postprints Distinct roles of CTLA-4 and TGF-b in CD4 + CD25 + regulatory T cell function distinct roles of CTLA-4 and TGF-b in CD4 + CD25 + regulatory T cell function","volume":"34","author":"Tang","year":"2004","journal-title":"Cytokines."},{"key":"10.1016\/j.trim.2021.101518_bb0335","doi-asserted-by":"crossref","first-page":"4376","DOI":"10.4049\/jimmunol.177.7.4376","article-title":"Blockade of CTLA-4 on CD4 + CD25 + regulatory T cells abrogates their function in vivo","volume":"177","author":"Read","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.trim.2021.101518_bb0340","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/imm.12754","article-title":"CTLA-4 expressed by FOXP3+ regulatory T cells prevents inflammatory tissue attack and not T-cell priming in arthritis","volume":"152","author":"Klocke","year":"2017","journal-title":"Immunology."},{"key":"10.1016\/j.trim.2021.101518_bb0345","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jneuroim.2005.11.003","article-title":"CD25 regulatory T cells determine secondary but not primary remission in EAE: impact on long-term disease progression","volume":"172","author":"G\u00e4rtner","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.trim.2021.101518_bb0350","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.micinf.2016.06.003","article-title":"Surface expression of inhibitory (CTLA-4) and stimulatory (OX40) receptors by CD4+ regulatory T cell subsets circulating in human malaria","volume":"18","author":"Gon\u00e7alves-Lopes","year":"2016","journal-title":"Microbes Infect."},{"key":"10.1016\/j.trim.2021.101518_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2020.155119","article-title":"Low expressions of PD-L1 and CTLA-4 by induced CD4+CD25+ Foxp3+ Tregs in patients with SLE and their correlation with the disease activity","volume":"133","author":"Zhao","year":"2020","journal-title":"Cytokine"},{"key":"10.1016\/j.trim.2021.101518_bb0360","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1080\/14712598.2019.1592155","article-title":"Immunotherapy for small cell lung cancer: mechanisms of resistance","volume":"19","author":"Hamilton","year":"2019","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.trim.2021.101518_bb0365","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/cei.13537","article-title":"CD40L-stimulated B cells for ex-vivo expansion of polyspecific non-human primate regulatory T cells for translational studies","volume":"203","author":"Alonso-Guallart","year":"2021","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.trim.2021.101518_bb0370","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-18731-y","article-title":"HIF-2\u03b1 is indispensable for regulatory T cell function","volume":"11","author":"Hsu","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trim.2021.101518_bb0375","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/cei.13453","article-title":"Directed differentiation of regulatory T cells from naive T cells and prevention of their inflammation-mediated instability using small molecules","volume":"201","author":"Haddadi","year":"2020","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.trim.2021.101518_bb0380","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.3389\/fimmu.2019.02361","article-title":"GMP-compliant manufacturing of NKG2D CAR memory T cells using CliniMACS prodigy","volume":"10","author":"Fern\u00e1ndez","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trim.2021.101518_bb0385","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4049\/jimmunol.170.1.28","article-title":"Cutting edge: L-selectin (CD62L) expression distinguishes small resting memory CD4 + T cells that preferentially respond to recall antigen","volume":"170","author":"Hengel","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.trim.2021.101518_bb0390","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41577-018-0001-y","article-title":"The full spectrum of human naive T cells","volume":"18","author":"van den Broek","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.trim.2021.101518_bb0395","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/j.intimp.2007.08.027","article-title":"Rapamycin inhibits differentiation of Th17 cells and promotes generation of FoxP3+ T regulatory cells","volume":"7","author":"Kopf","year":"2007","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.trim.2021.101518_bb0400","doi-asserted-by":"crossref","first-page":"8635","DOI":"10.1073\/pnas.0900621106","article-title":"Human memory FOXP3+ Tregs secrete IL-17 ex vivo and constitutively express the TH17 lineage-specific transcription factor ROR\u03b3t","volume":"106","author":"Ayyoub","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.trim.2021.101518_bb0405","doi-asserted-by":"crossref","first-page":"4793","DOI":"10.1073\/pnas.0900408106","article-title":"Identification of IL-17-producing FOXP3 + regulatory T cells in humans","volume":"106","author":"Voo","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.trim.2021.101518_bb0410","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.jpeds.2013.12.013","article-title":"Low thymic output, peripheral homeostasis deregulation, and hastened regulatory T cells differentiation in children with 22q11.2 deletion syndrome","volume":"164","author":"Ferrando-Mart\u00ednez","year":"2014","journal-title":"J. Pediatr."},{"key":"10.1016\/j.trim.2021.101518_bb0415","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.immuni.2009.03.019","article-title":"Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor","volume":"30","author":"Miyara","year":"2009","journal-title":"Immunity."},{"key":"10.1016\/j.trim.2021.101518_bb0420","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s00262-015-1729-x","article-title":"Monitoring regulatory T cells in clinical samples: consensus on an essential marker set and gating strategy for regulatory T cell analysis by flow cytometry","volume":"64","author":"Santegoets","year":"2015","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.trim.2021.101518_bb0425","article-title":"Response to comment on \u201ccutting edge: epigenetic regulation of Foxp3 defines a stable population of CD4 + regulatory T cells in tumors from mice and humans\u201d","volume":"194","author":"Waight","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.trim.2021.101518_bb0430","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.coi.2020.07.004","article-title":"New Treg cell-based therapies of autoimmune diseases: towards antigen-specific immune suppression","volume":"67","author":"Mikami","year":"2020","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.trim.2021.101518_bb0435","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nm.3432","article-title":"Pathogenic conversion of Foxp3 + T cells into TH17 cells in autoimmune arthritis","volume":"20","author":"Komatsu","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.trim.2021.101518_bb0440","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.it.2015.04.006","article-title":"Regulatory T cell identity: formation and maintenance","volume":"36","author":"Li","year":"2015","journal-title":"Trends Immunol."}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327421001581?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327421001581?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T18:02:17Z","timestamp":1760810537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966327421001581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":88,"alternative-id":["S0966327421001581"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2021.101518","relation":{},"ISSN":["0966-3274"],"issn-type":[{"value":"0966-3274","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and diagnostic potential of regulatory T cell markers: From bench to bedside","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2021.101518","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101518"}}